tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
These Are the Most and Least Likely Biotech Takeover Targets for 2026
PremiumMarket NewsThese Are the Most and Least Likely Biotech Takeover Targets for 2026
19d ago
Short Report: Vera Therapeutics bears retreat as stock rallies
Premium
The Fly
Short Report: Vera Therapeutics bears retreat as stock rallies
21d ago
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $900 from $540 at Piper Sandler
24d ago
Strong Adoption and Market Expansion Drive Buy Rating for Madrigal Pharmaceuticals’ Rezdiffra
PremiumRatingsStrong Adoption and Market Expansion Drive Buy Rating for Madrigal Pharmaceuticals’ Rezdiffra
2M ago
Madrigal price target raised to $620 from $568 at H.C. Wainwright
Premium
The Fly
Madrigal price target raised to $620 from $568 at H.C. Wainwright
2M ago
Madrigal Pharmaceuticals price target raised to $650 from $600 at Oppenheimer
Premium
The Fly
Madrigal Pharmaceuticals price target raised to $650 from $600 at Oppenheimer
2M ago
Madrigal price target raised to $568 from $500 at H.C. Wainwright
PremiumThe FlyMadrigal price target raised to $568 from $500 at H.C. Wainwright
2M ago
Madrigal Pharmaceuticals presents new data on Rezdiffra
Premium
The Fly
Madrigal Pharmaceuticals presents new data on Rezdiffra
2M ago
Madrigal’s Earnings Call: Rezdiffra’s Success and Future Outlook
Premium
Company Announcements
Madrigal’s Earnings Call: Rezdiffra’s Success and Future Outlook
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100